Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Operating Expenses (2017 - 2025)

Historic Operating Expenses for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $11.1 million.

  • Selectis Health's Operating Expenses fell 45.82% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.4 million, marking a year-over-year decrease of 111.38%. This contributed to the annual value of $42.2 million for FY2024, which is 770.0% down from last year.
  • Latest data reveals that Selectis Health reported Operating Expenses of $11.1 million as of Q3 2025, which was down 45.82% from $10.9 million recorded in Q2 2025.
  • Selectis Health's Operating Expenses' 5-year high stood at $12.2 million during Q4 2022, with a 5-year trough of $6.0 million in Q2 2021.
  • Moreover, its 5-year median value for Operating Expenses was $10.5 million (2023), whereas its average is $10.1 million.
  • In the last 5 years, Selectis Health's Operating Expenses soared by 10804.86% in 2021 and then plummeted by 1394.48% in 2024.
  • Quarter analysis of 5 years shows Selectis Health's Operating Expenses stood at $11.4 million in 2021, then grew by 7.72% to $12.2 million in 2022, then fell by 0.29% to $12.2 million in 2023, then dropped by 13.94% to $10.5 million in 2024, then grew by 6.11% to $11.1 million in 2025.
  • Its Operating Expenses was $11.1 million in Q3 2025, compared to $10.9 million in Q2 2025 and $10.9 million in Q1 2025.